NCT00000345View on ClinicalTrials.gov

Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10

PHASE1CompletedINTERVENTIONAL

0

Timeline

Start Date

April 30, 1996

Conditions

Opioid-Related Disorders

Interventions

DRUG

Lofexidine

Trial Locations (1)

90025

Friends Research Institute, Los Angeles

All Listed Sponsors

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00000345 - Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10 | Biotech Hunter | Biotech Hunter